A randomized, multicenter trial of shorter durations of hypomethylating agents in lower-risk Myelodysplastic Syndromes
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Ian Bouligny, Hetty Carraway, Mikkael Sekeres, Amy DeZern, Rami Komrokji, Richard Stone, Gail Roboz, Koji Sasaki, Guillermo Montalban-Bravo, Alex Bataller, Alexandre Bazinet, Danielle Hammond, Kelly Chien, Courtney DiNardo, Gautam Borthakur, Yesid Alvarado Valero, Farhad Ravandi, Naval Daver, Tapan Kadia, Naveen Pemmaraju, Nicholas Short, Jane Waukau, Matthew Rump, Colin Huck, Wei Qiao, Xuelin Huang, Elias Jabbour, Guillermo Garcia-Manero
Institutions: The University of Texas MD Anderson Cancer Center, Cleveland Clinic, University of Miami, Sylvester Comprehensive Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Moffitt Cancer Center, Dana-Farber Cancer Institute, Cornell University, Weill Cornell Medicine
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108479281